NeuroProof

NeuroProof is a CRO delivering services with its unique screening technology, which provides customers with high content phenotypic endpoints in the pre-clinical drug development. The MEA-neurochip technology is a powerful tool to characterize functional changes in compound-induced network activity in electrically active cell cultures, including stem cells. NeuroProof contributes to its customer's discovery and development projects with compelling high qualitative and robust data, accelerating their CNS drug development projects successfully and cost effectively. Read more about our services here. Find more information on our technology here.